SCHEMBL7361772

SCHEMBL7361772

COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(OCC(C)(C)O)cc1

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.69
EDNRA P25101 10/20 0.64
CCR4 P51679 8/20 0.52
PTGDR2 Q9Y5Y4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398790 0.89 ABCB11 (0.71) ABCB11EDNRACCR4PTGDR2
SCHEMBL7363388 0.89 ABCB11 (0.73) ABCB11EDNRACCR4PTGDR2
SCHEMBL7363876 0.88 ABCB11 (0.75) ABCB11EDNRACCR4
SCHEMBL7392493 0.87 ABCB11 (0.71) ABCB11EDNRACCR4PTGDR2
SCHEMBL7387146 0.86 ABCB11 (0.68) ABCB11EDNRACCR4PTGDR2
SCHEMBL7361201 0.86 ABCB11 (0.67) ABCB11EDNRACCR4
SCHEMBL7362617 0.85 ABCB11 (0.77) ABCB11EDNRACCR4
SCHEMBL7358677 0.85 ABCB11 (0.73) ABCB11EDNRACCR4
SCHEMBL7365241 0.85 ABCB11 (0.75) ABCB11EDNRACCR4
SCHEMBL30296218 0.84 ABCB11 (0.75) ABCB11EDNRACCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060475-A Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof ZENECA LIMITED (GB) 2000-05-09 US disclosed
US-5866568-A ENDOTHELIN RECEPTOR ANTAGONIST ACTIVITY ZENECA LIMITED (GB) 1999-02-02 US disclosed
EP-0832082-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1998-04-01 EP disclosed
WO-1996040681-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1996-12-19 WO disclosed